STRONGBRIDGE BIOPHARMA plc Forms 3, 4 and 5: Stock Options
Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 100 rows, 100 shown. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.
- 2021-10-05: Reporting owner Wilhoit Scott L.; Form 4; Security Stock Option (Right to Buy); Transaction D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e).
- 2021-10-05: Reporting owner Kollender Richard S; Form 4; Security Stock Option (Right to Buy); Transaction D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e).
- 2021-10-05: Reporting owner Cohen Fredric J.; Form 4; Security Stock Option (Right to Buy); Transaction D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e).
- 2021-10-05: Reporting owner JOHNSON JOHN; Form 4; Security Stock Option (Right to Buy); Transaction D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e).
| Transaction date | Reporting owner | Form | Security | Transaction | Shares | Price | Price that day | Filing |
|---|---|---|---|---|---|---|---|---|
| 2021-10-05 | Wilhoit Scott L. Officer (Chief Commercial Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −649,000 0 owned after | no price filed | 2021-10-06 | |
| 2021-10-05 | Kollender Richard S Officer (President and CFO) | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −544,918 0 owned after | no price filed | 2021-10-06 | |
| 2021-10-05 | Cohen Fredric J. Officer (Chief Medical Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −868,818 0 owned after | no price filed | 2021-10-06 | |
| 2021-10-05 | JOHNSON JOHN Director, Officer (Chief Executive Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −495,724 0 owned after | no price filed | 2021-10-06 | |
| 2021-10-05 | Steineger Hilde H Director | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −154,918 0 owned after | no price filed | 2021-10-06 | |
| 2021-10-05 | Steen Marten Director | 4 | Stock Option (Right to Buy) Derivative · Indirect · By HealthCap VI, L.P. | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −154,918 0 owned after | no price filed | 2021-10-06 | |
| 2021-10-05 | SHERMAN JEFFREY W Director | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −140,000 0 owned after | no price filed | 2021-10-06 | |
| 2021-10-05 | Kong Garheng Director | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −154,385 0 owned after | no price filed | 2021-10-06 | |
| 2021-10-05 | LONG STEPHEN J Officer (Chief Legal Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −714,045 0 owned after | no price filed | 2021-10-06 | |
| 2020-04-08 | JOHNSON JOHN Director, Officer (Executive Chairman) | 4 | Employee Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +87,500 87,500 owned after | $1.90 exercise price | 2020-04-10 | |
| 2020-01-27 | LONG STEPHEN J Officer (Chief Legal Officer) | 4 | Employee Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +200,000 200,000 owned after | $2.98 exercise price | 2020-01-29 | |
| 2020-01-27 | Kollender Richard S Officer (Chief Operating Officer) | 4 | Employee Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +200,000 200,000 owned after | $2.98 exercise price | 2020-01-29 | |
| 2020-01-27 | Wilhoit Scott L. Officer (Chief Commercial Officer) | 4 | Employee Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +200,000 200,000 owned after | $2.98 exercise price | 2020-01-29 | |
| 2020-01-27 | Lutz Robert Matthew Officer (Chief Financial Officer) | 4 | Employee Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +275,000 275,000 owned after | $2.98 exercise price | 2020-01-29 | |
| 2020-01-27 | Cohen Fredric J. Officer (Chief Medical Officer) | 4 | Employee Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +300,000 300,000 owned after | $2.98 exercise price | 2020-01-29 | |
| 2019-11-14 | JOHNSON JOHN Director, Officer (Executive Chairman) | 4 | Employee Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +275,000 275,000 owned after | $1.56 exercise price | 2019-11-18 | |
| 2019-09-04 holding as of filing | Lutz Robert Matthew Officer (Chief Financial Officer) | 3 | Stock Option (Right to Buy) Derivative · Direct | Holding | $8.06 exercise price | 2019-09-04 | ||
| 2019-09-04 holding as of filing | Lutz Robert Matthew Officer (Chief Financial Officer) | 3 | Stock Option (Right to Buy) Derivative · Direct | Holding | $10.74 exercise price | 2019-09-04 | ||
| 2019-09-04 holding as of filing | Lutz Robert Matthew Officer (Chief Financial Officer) | 3 | Stock Option (Right to Buy) Derivative · Direct | Holding | $13.43 exercise price | 2019-09-04 | ||
| 2019-09-04 holding as of filing | Lutz Robert Matthew Officer (Chief Financial Officer) | 3 | Stock Option (Right to Buy) Derivative · Direct | Holding | $14.37 exercise price | 2019-09-04 | ||
| 2019-09-04 holding as of filing | Lutz Robert Matthew Officer (Chief Financial Officer) | 3 | Stock Option (Right to Buy) Derivative · Direct | Holding | $14.37 exercise price | 2019-09-04 | ||
| 2019-09-04 holding as of filing | Lutz Robert Matthew Officer (Chief Financial Officer) | 3 | Stock Option (Right to Buy) Derivative · Direct | Holding | $14.37 exercise price | 2019-09-04 | ||
| 2019-09-04 holding as of filing | Lutz Robert Matthew Officer (Chief Financial Officer) | 3 | Stock Option (Right to Buy) Derivative · Direct | Holding | $3.94 exercise price | 2019-09-04 | ||
| 2019-09-04 holding as of filing | Lutz Robert Matthew Officer (Chief Financial Officer) | 3 | Stock Option (Right to Buy) Derivative · Direct | Holding | $2.90 exercise price | 2019-09-04 | ||
| 2019-09-04 holding as of filing | Lutz Robert Matthew Officer (Chief Financial Officer) | 3 | Stock Option (Right to Buy) Derivative · Direct | Holding | $6.65 exercise price | 2019-09-04 | ||
| 2019-09-04 holding as of filing | Lutz Robert Matthew Officer (Chief Financial Officer) | 3 | Stock Option (Right to Buy) Derivative · Direct | Holding | $4.67 exercise price | 2019-09-04 | ||
| 2019-09-03 | Kollender Richard S Officer (Chief Operating Officer) | 4 | Employee Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +215,000 215,000 owned after | $2.57 exercise price | 2019-09-04 | |
| 2019-06-05 holding as of filing | Wilhoit Scott L. Officer (Chief Commercial Officer) | 3 | Stock Option (Right to Buy) Derivative · Direct | Holding | $2.30 exercise price | 2019-06-05 | ||
| 2019-06-05 holding as of filing | Wilhoit Scott L. Officer (Chief Commercial Officer) | 3 | Stock Option (Right to Buy) Derivative · Direct | Holding | $2.90 exercise price | 2019-06-05 | ||
| 2019-06-05 holding as of filing | Wilhoit Scott L. Officer (Chief Commercial Officer) | 3 | Stock Option (Right to Buy) Derivative · Direct | Holding | $6.65 exercise price | 2019-06-05 | ||
| 2019-06-05 holding as of filing | Wilhoit Scott L. Officer (Chief Commercial Officer) | 3 | Stock Option (Right to Buy) Derivative · Direct | Holding | $4.67 exercise price | 2019-06-05 | ||
| 2019-05-28 | Wilhoit Scott L. Officer (Chief Commercial Officer) | 4 | Employee Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +50,000 50,000 owned after | $2.84 exercise price | 2019-06-05 | |
| 2019-02-20 | Cohen Fredric J. Officer (Chief Medical Officer) | 4 | Employee Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +118,000 118,000 owned after | $4.67 exercise price | 2019-02-22 | |
| 2019-02-20 | DAVIS A BRIAN Officer (Chief Financial Officer) | 4 | Employee Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +108,500 108,500 owned after | $4.67 exercise price | 2019-02-22 | |
| 2019-02-20 | LONG STEPHEN J Officer (Chief Legal Officer) | 4 | Employee Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +108,500 108,500 owned after | $4.67 exercise price | 2019-02-22 | |
| 2019-02-20 | Pauls Matthew Director, Officer (President & CEO) | 4 | Employee Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +400,000 400,000 owned after | $4.67 exercise price | 2019-02-22 | |
| 2018-05-15 | Steineger Hilde H Director | 4 | Stock Options (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +40,000 40,000 owned after | $7.75 exercise price | 2018-05-17 | |
| 2018-05-15 | Steen Marten Director | 4 | Stock Options (Right to Buy) Derivative · Indirect · By HealthCap VI, L.P. | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +40,000 40,000 owned after | $7.75 exercise price | 2018-05-17 | |
| 2018-05-15 | SHERMAN JEFFREY W Director | 4 | Stock Options (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +40,000 40,000 owned after | $7.75 exercise price | 2018-05-17 | |
| 2018-05-15 | Kong Garheng Director | 4 | Stock Options (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +40,000 40,000 owned after | $7.75 exercise price | 2018-05-17 | |
| 2018-05-15 | Kollender Richard S Director | 4 | Stock Options (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +40,000 40,000 owned after | $7.75 exercise price | 2018-05-17 | |
| 2018-05-15 | JOHNSON JOHN Director | 4 | Stock Options (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +40,000 40,000 owned after | $7.75 exercise price | 2018-05-17 | |
| 2018-02-05 | Pauls Matthew Director, Officer (President & CEO) | 4 | Employee Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +350,000 350,000 owned after | $6.65 exercise price | 2018-02-06 | |
| 2018-02-05 | Cohen Fredric J. Officer (Chief Medical Officer) | 4 | Employee Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +116,000 116,000 owned after | $6.65 exercise price | 2018-02-06 | |
| 2018-02-05 | DAVIS A BRIAN Officer (Chief Financial Officer) | 4 | Employee Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +115,000 115,000 owned after | $6.65 exercise price | 2018-02-06 | |
| 2018-02-05 | LONG STEPHEN J Officer (Chief Legal Officer) | 4 | Employee Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +114,000 114,000 owned after | $6.65 exercise price | 2018-02-06 | |
| 2018-01-02 holding as of filing | DAVIS A BRIAN Officer (Chief Financial Officer) | 3 | Stock Option (Right to Buy) Derivative · Direct | Holding | $15.71 exercise price | 2018-01-02 | ||
| 2018-01-02 holding as of filing | DAVIS A BRIAN Officer (Chief Financial Officer) | 3 | Stock Option (Right to Buy) Derivative · Direct | Holding | $15.71 exercise price | 2018-01-02 | ||
| 2018-01-02 holding as of filing | DAVIS A BRIAN Officer (Chief Financial Officer) | 3 | Stock Option (Right to Buy) Derivative · Direct | Holding | $15.71 exercise price | 2018-01-02 | ||
| 2018-01-02 holding as of filing | DAVIS A BRIAN Officer (Chief Financial Officer) | 3 | Stock Option (Right to Buy) Derivative · Direct | Holding | $15.71 exercise price | 2018-01-02 | ||
| 2018-01-02 holding as of filing | DAVIS A BRIAN Officer (Chief Financial Officer) | 3 | Stock Option (Right to Buy) Derivative · Direct | Holding | $18.80 exercise price | 2018-01-02 | ||
| 2018-01-02 holding as of filing | DAVIS A BRIAN Officer (Chief Financial Officer) | 3 | Stock Option (Right to Buy) Derivative · Direct | Holding | $3.94 exercise price | 2018-01-02 | ||
| 2018-01-02 holding as of filing | DAVIS A BRIAN Officer (Chief Financial Officer) | 3 | Stock Option (Right to Buy) Derivative · Direct | Holding | $2.90 exercise price | 2018-01-02 | ||
| 2018-01-02 holding as of filing | Cohen Fredric J. Officer (Chief Medical Officer) | 3 | Stock Option (Right to Buy) Derivative · Direct | Holding | $18.12 exercise price | 2018-01-02 | ||
| 2018-01-02 holding as of filing | Cohen Fredric J. Officer (Chief Medical Officer) | 3 | Stock Option (Right to Buy) Derivative · Direct | Holding | $3.94 exercise price | 2018-01-02 | ||
| 2018-01-02 holding as of filing | Cohen Fredric J. Officer (Chief Medical Officer) | 3 | Stock Option (Right to Buy) Derivative · Direct | Holding | $4.16 exercise price | 2018-01-02 | ||
| 2018-01-02 holding as of filing | Cohen Fredric J. Officer (Chief Medical Officer) | 3 | Stock Option (Right to Buy) Derivative · Direct | Holding | $3.90 exercise price | 2018-01-02 | ||
| 2018-01-02 holding as of filing | Cohen Fredric J. Officer (Chief Medical Officer) | 3 | Stock Option (Right to Buy) Derivative · Direct | Holding | $2.90 exercise price | 2018-01-02 | ||
| 2018-01-02 holding as of filing | Pauls Matthew Director, Officer (President & CEO) | 3 | Stock Option (Right to Buy) Derivative · Direct | Holding | $8.06 exercise price | 2018-01-02 | ||
| 2018-01-02 holding as of filing | Pauls Matthew Director, Officer (President & CEO) | 3 | Stock Option (Right to Buy) Derivative · Direct | Holding | $10.74 exercise price | 2018-01-02 | ||
| 2018-01-02 holding as of filing | Pauls Matthew Director, Officer (President & CEO) | 3 | Stock Option (Right to Buy) Derivative · Direct | Holding | $13.43 exercise price | 2018-01-02 | ||
| 2018-01-02 holding as of filing | Pauls Matthew Director, Officer (President & CEO) | 3 | Stock Option (Right to Buy) Derivative · Direct | Holding | $15.71 exercise price | 2018-01-02 | ||
| 2018-01-02 holding as of filing | Pauls Matthew Director, Officer (President & CEO) | 3 | Stock Option (Right to Buy) Derivative · Direct | Holding | $15.71 exercise price | 2018-01-02 | ||
| 2018-01-02 holding as of filing | Pauls Matthew Director, Officer (President & CEO) | 3 | Stock Option (Right to Buy) Derivative · Direct | Holding | $15.71 exercise price | 2018-01-02 | ||
| 2018-01-02 holding as of filing | Pauls Matthew Director, Officer (President & CEO) | 3 | Stock Option (Right to Buy) Derivative · Direct | Holding | $15.71 exercise price | 2018-01-02 | ||
| 2018-01-02 holding as of filing | Pauls Matthew Director, Officer (President & CEO) | 3 | Stock Option (Right to Buy) Derivative · Direct | Holding | $3.94 exercise price | 2018-01-02 | ||
| 2018-01-02 holding as of filing | Pauls Matthew Director, Officer (President & CEO) | 3 | Stock Option (Right to Buy) Derivative · Direct | Holding | $2.90 exercise price | 2018-01-02 | ||
| 2018-01-02 holding as of filing | LONG STEPHEN J Officer (Chief Legal Officer) | 3 | Stock Option (Right to Buy) Derivative · Direct | Holding | $15.71 exercise price | 2018-01-02 | ||
| 2018-01-02 holding as of filing | LONG STEPHEN J Officer (Chief Legal Officer) | 3 | Stock Option (Right to Buy) Derivative · Direct | Holding | $15.71 exercise price | 2018-01-02 | ||
| 2018-01-02 holding as of filing | LONG STEPHEN J Officer (Chief Legal Officer) | 3 | Stock Option (Right to Buy) Derivative · Direct | Holding | $15.71 exercise price | 2018-01-02 | ||
| 2018-01-02 holding as of filing | LONG STEPHEN J Officer (Chief Legal Officer) | 3 | Stock Option (Right to Buy) Derivative · Direct | Holding | $15.71 exercise price | 2018-01-02 | ||
| 2018-01-02 holding as of filing | LONG STEPHEN J Officer (Chief Legal Officer) | 3 | Stock Option (Right to Buy) Derivative · Direct | Holding | $18.80 exercise price | 2018-01-02 | ||
| 2018-01-02 holding as of filing | LONG STEPHEN J Officer (Chief Legal Officer) | 3 | Stock Option (Right to Buy) Derivative · Direct | Holding | $3.94 exercise price | 2018-01-02 | ||
| 2018-01-02 holding as of filing | LONG STEPHEN J Officer (Chief Legal Officer) | 3 | Stock Option (Right to Buy) Derivative · Direct | Holding | $2.90 exercise price | 2018-01-02 | ||
| 2018-01-02 holding as of filing | Steen Marten Director | 3 | Stock Option (Right to Buy) Derivative · Indirect · By HealthCap VI, L.P. | Holding | $17.55 exercise price | 2018-01-02 | ||
| 2018-01-02 holding as of filing | Steen Marten Director | 3 | Stock Option (Right to Buy) Derivative · Indirect · By HealthCap VI, L.P. | Holding | $17.55 exercise price | 2018-01-02 | ||
| 2018-01-02 holding as of filing | Steen Marten Director | 3 | Stock Option (Right to Buy) Derivative · Indirect · By HealthCap VI, L.P. | Holding | $5.50 exercise price | 2018-01-02 | ||
| 2018-01-02 holding as of filing | Steen Marten Director | 3 | Stock Option (Right to Buy) Derivative · Indirect · By HealthCap VI, L.P. | Holding | $4.40 exercise price | 2018-01-02 | ||
| 2018-01-02 holding as of filing | Steineger Hilde H Director | 3 | Stock Option (Right to Buy) Derivative · Direct | Holding | $17.55 exercise price | 2018-01-02 | ||
| 2018-01-02 holding as of filing | Steineger Hilde H Director | 3 | Stock Option (Right to Buy) Derivative · Direct | Holding | $17.55 exercise price | 2018-01-02 | ||
| 2018-01-02 holding as of filing | Steineger Hilde H Director | 3 | Stock Option (Right to Buy) Derivative · Direct | Holding | $5.50 exercise price | 2018-01-02 | ||
| 2018-01-02 holding as of filing | Steineger Hilde H Director | 3 | Stock Option (Right to Buy) Derivative · Direct | Holding | $4.40 exercise price | 2018-01-02 | ||
| 2018-01-02 holding as of filing | SHERMAN JEFFREY W Director | 3 | Stock Option (Right to Buy) Derivative · Direct | Holding | $5.22 exercise price | 2018-01-02 | ||
| 2018-01-02 holding as of filing | SHERMAN JEFFREY W Director | 3 | Stock Option (Right to Buy) Derivative · Direct | Holding | $4.40 exercise price | 2018-01-02 | ||
| 2018-01-02 holding as of filing | Kong Garheng Director | 3 | Stock Option (Right to Buy) Derivative · Direct | Holding | $17.55 exercise price | 2018-01-02 | ||
| 2018-01-02 holding as of filing | Kong Garheng Director | 3 | Stock Option (Right to Buy) Derivative · Direct | Holding | $17.55 exercise price | 2018-01-02 | ||
| 2018-01-02 holding as of filing | Kong Garheng Director | 3 | Stock Option (Right to Buy) Derivative · Direct | Holding | $5.50 exercise price | 2018-01-02 | ||
| 2018-01-02 holding as of filing | Kong Garheng Director | 3 | Stock Option (Right to Buy) Derivative · Direct | Holding | $4.40 exercise price | 2018-01-02 | ||
| 2018-01-02 holding as of filing | Kollender Richard S Director | 3 | Stock Option (Right to Buy) Derivative · Direct | Holding | $10.74 exercise price | 2018-01-02 | ||
| 2018-01-02 holding as of filing | Kollender Richard S Director | 3 | Stock Option (Right to Buy) Derivative · Direct | Holding | $13.43 exercise price | 2018-01-02 | ||
| 2018-01-02 holding as of filing | Kollender Richard S Director | 3 | Stock Option (Right to Buy) Derivative · Direct | Holding | $16.11 exercise price | 2018-01-02 | ||
| 2018-01-02 holding as of filing | Kollender Richard S Director | 3 | Stock Option (Right to Buy) Derivative · Direct | Holding | $17.55 exercise price | 2018-01-02 | ||
| 2018-01-02 holding as of filing | Kollender Richard S Director | 3 | Stock Option (Right to Buy) Derivative · Direct | Holding | $5.50 exercise price | 2018-01-02 | ||
| 2018-01-02 holding as of filing | Kollender Richard S Director | 3 | Stock Option (Right to Buy) Derivative · Direct | Holding | $4.40 exercise price | 2018-01-02 | ||
| 2018-01-02 holding as of filing | JOHNSON JOHN Director | 3 | Stock Option (Right to Buy) Derivative · Direct | Holding | $10.74 exercise price | 2018-01-02 | ||
| 2018-01-02 holding as of filing | JOHNSON JOHN Director | 3 | Stock Option (Right to Buy) Derivative · Direct | Holding | $13.43 exercise price | 2018-01-02 | ||
| 2018-01-02 holding as of filing | JOHNSON JOHN Director | 3 | Stock Option (Right to Buy) Derivative · Direct | Holding | $16.11 exercise price | 2018-01-02 | ||
| 2018-01-02 holding as of filing | JOHNSON JOHN Director | 3 | Stock Option (Right to Buy) Derivative · Direct | Holding | $17.55 exercise price | 2018-01-02 | ||
| 2018-01-02 holding as of filing | JOHNSON JOHN Director | 3 | Stock Option (Right to Buy Derivative · Direct | Holding | $5.50 exercise price | 2018-01-02 | ||
| 2018-01-02 holding as of filing | JOHNSON JOHN Director | 3 | Stock Option (Right to Buy Derivative · Direct | Holding | $4.40 exercise price | 2018-01-02 |